Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 359Endometrial Neoplasms 207Uterine Cervical Neoplasms 187Breast Neoplasms 109Fallopian Tube Neoplasms 96Colorectal Neoplasms 83Carcinoma, Non-Small-Cell Lung 76Neoplasms 65Pancreatic Neoplasms 59Stomach Neoplasms 55Neoplasm Metastasis 51Prostatic Neoplasms 50Lung Neoplasms 46Melanoma 43Carcinoma, Ovarian Epithelial 41Triple Negative Breast Neoplasms 38Squamous Cell Carcinoma of Head and Neck 36Esophageal Neoplasms 35Carcinoma, Renal Cell 35Colonic Neoplasms 31Urinary Bladder Neoplasms 30Peritoneal Neoplasms 29Head and Neck Neoplasms 28Vulvar Neoplasms 26Uterine Neoplasms 26Carcinoma, Hepatocellular 26Carcinoma, Transitional Cell 24Small Cell Lung Carcinoma 23Sarcoma 20Rectal Neoplasms 19

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulin Resistance × Gynecologic × 90 days × Clear all
NCT07065552 2026-04-28

Tirzepatide in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡